| Literature DB >> 35682149 |
Yoshiaki Tadokoro1, Takumi Hasegawa1, Daisuke Takeda1, Aki Murakami1, Nanae Yatagai1, Eiji Iwata1, Izumi Saito1, Junya Kusumoto1, Masaya Akashi1.
Abstract
A standard treatment for osteoradionecrosis (ORN) has not yet been established because of the diversity. Therefore, identifying the risk factors for a poor prognosis is essential. This study retrospectively investigated the factors associated with the prognosis of ORN in 68 patients. Relevant clinical data of all patients were obtained. Of the patients, 16 who underwent extensive surgery underwent histopathological analysis. The necrotic changes of the anterior and posterior margins in the cortical and cancellous bones were investigated. Multivariate analyses showed statistically significant associations between poor prognosis in patients with ORN and high radiation dose (hazard ratio [HR] 1.15), orocutaneous fistula (HR 2.93), and absence of sequestration (HR 2.49). Histopathological analysis showed a viable anterior margin of the middle portion of the cortical bone for all recovered cases; in contrast, most cases (75%) with a poor prognosis showed necrotic changes. The anterior margin of the cancellous bone was viable and resilient to high irradiation, regardless of the prognosis. These results suggest that patients with orocutaneous fistula should receive early surgical intervention, even if the affected area is limited or asymptomatic. In extensive surgery, a sufficient safety margin of necrotic bone, particularly in the anterior region, is required to improve the prognosis.Entities:
Keywords: extensive resection; orocutaneous fistula; osteoradionecrosis; radiation dose; sequestration
Mesh:
Year: 2022 PMID: 35682149 PMCID: PMC9180928 DOI: 10.3390/ijerph19116565
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Computed tomography images of a male patient (age 66) who received external radiotherapy (70 Gy) for nasopharyngeal carcinoma and was treated with antibiotics. An extensive osteolytic lesion (white arrows) is seen in the left mandible. Osteosclerosis is observed in the right mandible.
Figure 2Computed tomography images of a male patient (age 69) who received external radiotherapy (60 Gy) for nasopharyngeal carcinoma and was treated with right segmental mandibulectomy with simultaneous left fibular free flap reconstruction. Periosteal reaction (white arrows) and sequestration (black arrows: devitalized bone) in the right mandible.
Figure 3Histopathological images of a male patient (age 83) who received radiotherapy (60 Gy) for oropharyngeal carcinoma and was treated with right segmental mandibulectomy. The specimens were stained with hematoxylin and eosin—original magnification ×4 and ×40. (A) A resected bone specimen. The anterior and posterior specimens were prepared separately from the true resection margin to avoid heat artifacts caused by the surgical saw (white lines). The most advanced area of bone destruction was observed in the white box specimen. (B) White box specimen in (A); the most advanced area of bone destruction (white box). In the enlarged view, osteocyte nuclei within the lacunae are absent. (C) Anterior margin. (D) Viable cancellous bone. (E) The viable cortical bone at the middle level of the mandible. In the enlarged view, there are osteocytes and blood vessels in the Haversian canal. (F) Necrotic cortical bone near the inferior border of the mandible. In the enlarged view, the Haversian canal has been completely obstructed. (G) Posterior margin. (H) Viable cancellous bone. (I) The viable cortical bone in the middle portion of the mandible. In the enlarged view, there is a lack of osteocyte nuclei despite the presence of viable blood vessels in the Haversian canal. (J) Viable cortical bone near the inferior border of the mandible. In the enlarged view, there are osteocytes and blood vessels in the Haversian canal.
Characteristics of patients according to whether osteoradionecrosis led to a poor prognosis.
| Variables | Prognosis | ||
|---|---|---|---|
| Good | Poor | ||
| Sex | <0.550 * | ||
| Male | 27 (84.4) | 28 (80.9) | |
| Female | 5 (15.6) | 8 (19.1) | |
| Age | 0.431 ** | ||
| Range (years) | 54–84 | 21–90 | |
| Mean ± SD | 69.1 ± 8.0 | 69.3 ± 13.3 | |
| ORN Stage | <0.013 *** | ||
| Stage 1 | 10 (31.3) | 6 (16.7) | |
| Stage 2 | 0 (0.0) | 3 (8.3) | |
| Stage 3 | 5 (15.6) | 16 (44.4) | |
| Stage 4 | 17 (53.1) | 11(30.6) | |
| Jawbone | <0.886 *** | ||
| Maxilla | 4 (12.5) | 6 (16.7) | |
| Mandible | 25 (78.1) | 27 (75.0) | |
| Maxilla and Mandible | 3 (9.4) | 3 (8.3) | |
| Onset Site | 0.166 * | ||
| Molar region | 27 (84.4) | 25 (69.4) | |
| Incisal region | 5 (15.6) | 11 (30.6) | |
| Onset Trigger | 0.257 *** | ||
| Spontaneous onset | 20 (62.5) | 18 (50.0) | |
| Tooth extraction | 7 (21.9) | 8 (22.2) | |
| Infection | 5 (15.6) | 6 (16.7) | |
| Others | 0 (0.0) | 4 (11.1) | |
| Primary Tumor Site | 0.401 *** | ||
| Oral | 8 (25.0) | 14 (38.9) | |
| Pharynx | 22 (68.8) | 19 (52.8) | |
| Others | 2 (6.3) | 3 (8.3) | |
| Radiation Dose | 0.003 ** | ||
| Range (Gy) | 30–70 | 60–81 | |
| Mean ± SD | 63.7 ± 9.0 | 66.4 ± 6.9 | |
| Observation Period | <0.390 ** | ||
| Range (months) | 1–144 | 0–144 | |
| Mean ± SD | 80.8 ± 39.4 | 71.2 ± 40.6 | |
| Medical History | |||
| Hypertension | <0.550 * | ||
| No | 24 (75.0) | 30 (83.3) | |
| Yes | 8 (25.0) | 6 (16.7) | |
| Diabetes | 1.000 * | ||
| No | 31 (96.9) | 35 (97.2) | |
| Yes | 1 (3.1) | 1 (2.8) | |
| Steroid Therapy | |||
| No | 29 (90.6) | 36 (95.6) | |
| Yes | 3 (9.4) | 0 (4.4) | |
| Clinical Symptoms | 1.000 * | ||
| Pain | |||
| No | 6 (18.8) | 6 (16.7) | |
| Yes | 26 (81.3) | 30 (83.3) | |
| Nerve Paralysis | 0.182 * | ||
| No | 21 (65.6) | 29 (80.6) | |
| Yes | 11 (34.4) | 7 (19.4) | |
| Pus Discharge | 1.000 * | ||
| No | 13 (40.6) | 14 (38.9) | |
| Yes | 19 (59.4) | 22 (61.1) | |
| Pathological Fracture | 0.461 * | ||
| No | 27 (84.4) | 33 (91.7) | |
| Yes | 5 (15.6) | 3 (8.3) | |
| Orocutaneous Fistula | 0.021 * | ||
| No | 29 (90.6) | 24 (77.9) | |
| Yes | 3 (9.4) | 12 (33.3) | |
| Trismus | 0.331 * | ||
| No | 18 (56.3) | 15 (41.7) | |
| Yes | 14 (43.8) | 21 (58.3) | |
| Treatment | 0.016 *** | ||
| Conservative Therapy | 12 (37.5) | 24 (66.7) | |
| Minimal Debridement | 2 (6.3) | 4 (11.1) | |
| Resection | 18 (56.3) | 8 (22.2) | |
| Osteolysis | 1.000 * | ||
| No | 4 (12.5) | 5 (13.9) | |
| Yes | 28 (87.5) | 31 (86.1) | |
| Osteosclerosis | 0.443 * | ||
| No | 9 (28.1) | 14 (38.9) | |
| Yes | 23 (71.9) | 22 (61.1) | |
| Periosteal Reaction | 0.616 * | ||
| No | 31 (96.9) | 33 (91.7) | |
| Yes | 1 (4.0) | 3 (3.1) | |
| Sequestration | 0.047 * | ||
| No | 15 (46.9) | 26 (72.2) | |
| Yes | 17 (53.1) | 10 (27.8) | |
*: Fisher’s exact test. **: Mann–Whitney U test. ***: Chi-squared test.
Results of multivariate logistic regression analysis of the risk factors for ORN.
| 95% CI | ||||
|---|---|---|---|---|
| Variable | Hazard Ratio | Lower | Upper | |
| Radiation Dose | 0.005 | 1.148 | 1.042 | 1.264 |
| Orocutaneous fistula | 0.005 | 2.929 | 1.374 | 6.246 |
| Non-Sequestration | 0.028 | 2.493 | 1.106 | 5.624 |
CI: Confidence interval.
Histopathological results of the bone specimens. (V: Viable; N: Necrosis). (A) Recovered cases. (B) Poor prognosis cases.
| Case Number | Anterior Margin | Medial Area | Posterior Margin | ||||
|---|---|---|---|---|---|---|---|
| Cortical Bone | Cortical Bone | Cancellous Bone | Cancellous Bone | Cortical Bone | Cortical Bone | Cancellous Bone | |
| ( | |||||||
| 1 | V | V | V | N | V | V | V |
| 2 | N | V | V | V | V | V | V |
| 3 | V | V | V | N | V | V | V |
| 4 | V | V | V | N | N | V | V |
| 5 | V | V | V | N | V | V | V |
| 6 | N | V | V | N | V | V | V |
| 7 | N | V | V | N | V | V | V |
| 8 | N | V | V | V | N | N | V |
| 9 | V | V | V | V | V | V | V |
| 10 | N | V | V | N | V | V | V |
| 11 | N | V | V | N | N | N | N |
| 12 | V | V | V | N | V | V | N |
| Necrosis rate (%) | 50 | 0 | 0 | 75 | 25 | 16.7 | 16.7 |
| ( | |||||||
| 13 | N | N | V | N | N | N | V |
| 14 | N | N | V | N | V | V | N |
| 15 | N | V | V | N | N | V | N |
| 16 | N | N | V | N | N | N | V |
| Necrosis rate (%) | 100 | 75 | 0 | 100 | 75 | 50 | 50 |